Cita APA (7a ed.)
NI, M., TI, Y., QI, Y., ZHANG, M., Duan, D. D., YAO, C., . . . BU, P. (2025). Study design and rationale of the TXL-CAP trial: A randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques. Journal of Geriatric Cardiology, 22(7), 615-625.
Cita Chicago Style (17a ed.)
NI, Mei, Yun TI, Yan QI, Meng ZHANG, Dayue Darrel Duan, Chen YAO, Zhen-Hua JIA, Yun ZHANG, y Pei-Li BU. "Study Design and Rationale of the TXL-CAP Trial: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial Assessing the Effect of Tongxinluo Capsules on the Stability of Coronary Atherosclerotic Plaques." Journal of Geriatric Cardiology 22, no. 7 (2025): 615-625.
Cita MLA (9a ed.)
NI, Mei, et al. "Study Design and Rationale of the TXL-CAP Trial: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial Assessing the Effect of Tongxinluo Capsules on the Stability of Coronary Atherosclerotic Plaques." Journal of Geriatric Cardiology, vol. 22, no. 7, 2025, pp. 615-625.
Precaución: Estas citas no son 100% exactas.